Open access · OA
via Europe PMC
In Vivo Partial Cell Reprogramming With Yamanaka Factors Reduced Ischemic Brain Damage in Aging Mice.
Mallavibarrena PR, Martín-López G, Rodríguez-Morales J, Ávila J, Hernández F, Pérez-Álvarez MJ.
Aging cell · 2026
Abstract
Aging is associated with functional decline and reduced regenerative capacity in the brain, is also the strongest risk factor for ischemic stroke, which remains a leading cause of mortality and long-term disability worldwide, and is associated with impaired functional recovery. Here, we investigated whether short-term partial cellular reprogramming through cyclic expression of Yamanaka factors (OSKM) in a Tet-ON mouse model under Rosa-26 promoter has any impact on ischemic damage in aged mice. To assess ischemic resilience, mice underwent permanent middle cerebral artery occlusion (pMCAo). Forty-eight hours after ischemia, OSKM-induced mice displayed significantly smaller damaged area compared with wild-type controls, accompanied by improved neurological scores and enhanced performance in the tightrope test, suggesting preserved sensorimotor abilities. Notably, myelin integrity was preserved in OSKM-treated mice, as shown by Black-Gold staining and stable MAG and MBP expression, whereas wild-type mice exhibited pronounced demyelination. Given the role of oligodendrocytes in myelin maintenance, we quantified the abundance of their different populations. OSKM induction significantly increased total oligodendrocytes (Olig2<sup>+</sup>) and oligodendrocyte precursor cells (PDGFRα<sup>+</sup>) following ischemia, suggesting an enhanced reparative response. Moreover, partial reprogramming(definition) preserved neuronal density in the ischemic cortex and prevented the marked astrocytic activation observed in wild-type mice, while microglial responses remained comparable across genotypes. These findings demonstrate that cyclic partial reprogramming in aged mice reduces ischemic damage, highlighting OSKM induction as a promising strategy for enhancing brain resilience during cerebrovascular accidents.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.1111/acel.70776
- Canonical
- link ↗
- Fetched
- 2026-10-27 MST
Cite this
APA
PR, M., G, M., J, R., J, �., F, H., & MJ., P. (2026). In Vivo Partial Cell Reprogramming With Yamanaka Factors Reduced Ischemic Brain Damage in Aging Mice. <em>Aging cell</em>. https://doi.org/10.1111/acel.70776
Vancouver
PR M, G M, J R, J �, F H, MJ. P. In Vivo Partial Cell Reprogramming With Yamanaka Factors Reduced Ischemic Brain Damage in Aging Mice. Aging cell. 2026. doi:10.1111/acel.70776.
BibTeX
@article{mallavibarrena2026InVivo,
title = {In Vivo Partial Cell Reprogramming With Yamanaka Factors Reduced Ischemic Brain Damage in Aging Mice.},
author = {Mallavibarrena PR and Martín-López G and Rodríguez-Morales J and Ávila J and Hernández F and Pérez-Álvarez MJ.},
journal = {Aging cell},
year = {2026},
doi = {10.1111/acel.70776},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Aging Cell 2026
Open access · CC-BY
In Vivo Partial Cell Reprogramming With Yamanaka Factors Reduced Ischemic Brain Damage in Aging Mice
Aging cell 2026
Open access · OA
In Vivo Partial Cell Reprogramming With Yamanaka Factors Reduced Ischemic Brain Damage in Aging Mice
EMBO Molecular Medicine 2026
Open access · CC-BY
Tomatidine is a senotherapeutic compound that improves cognitive function and reduces cellular senescence in aged mice
Innovation in Aging 2024
Open access · CC-BY
PARTIAL REPROGRAMMING OF THE AGING NEUROGENIC NICHE
Journal of Neuroinflammation 2026
Open access · CC-BY
Epigenetic brain reprogramming rejuvenates neuro-immune circuits to reverse Alzheimer’s disease pathology and systemic bone loss
Transplantation 2018
Citation only